Latest News
Should You Be Looking To Stocks Like Bakkt As Crypto Meets The Banks?
Bakkt enters partnership with Manasquan Bank allowing customers to trade and hold crypto Arguably paves the way for future partnerships - all eyes on Bakkt and its competitors...
XL Fleet Is Down 83% For The Year, Is The Stock Undervalued?
Electrification solutions offer an under-hyped slice of a ballooning market XL Fleet announces the completion of Power Apex's charging infrastructure Down 83% annually, XL Fleet might be seriously undervalued
Investor Fraud & SPAC Danger, The Crux of Nikola’s $125M Fine
Nikola fined $125M following investor fraud investigations linking back to Trevor Milton Char of SEC calls for increased scrutiny regarding SPAC mergers Investors should tread carefully following Nikola's 'misled'
Micron Up 7% Premarket On Earnings Beat – Is The Revaluation Starting?
Micron beats analyst forecasts and the stock is up 7% premarket as a result The big question is whether this presages a general revaluation of Micron stock
Greatland Gold Says Newcrest to Exercise 5% Havieron Option
Greatland Gold's share price is up 14% Newcrest Mining asks to exercise its option of an additional 5% stake in Havieron copper-gold project
Aridis Pharma Jumps 88% Premarket On Omicron Effectiveness News
Aridis announced yesterday that its antibody cocktail works on the omicron variant The stock started rising at the release and is up 88% premarket this mor
Itaconix Jumps 33% On Restarting Production
Itaconix is a deep tech startup spun out from research at the University of Bristol This is a difficult but potentially exciting field
Atlantic Lithium Excitement Over West Africa Drilling Results Fades
Atlantic is drilling for lithium prospects in West Africa As is usual with junior miners good results produce share price movements
Glaxo Improves on FDA’s HIV Prevention Approval
Glaxo’s ViiV has FDA approval of Apretude for HIV prevention There is also the spin off of the consumer healthcare division
Xtract Resources Down 2% On “Satisfactory” Bushranger Drilling Assay
“Satisfactory” results from a drilling programme or assay are OK We’d all also rather prefer better than merely satisfactory
Open Orphan Rises As hVIVO Signs New £5m Human Challenge Study Contract
Open Orphan's subsidiary, hVIVO wins £5m human challenge study contract The study will begin in H2 2022 assessing an antiviral drug
Oracle Dives Into Healthcare with $28B Acquisition of Cerner Corp
Oracle announces acquisition of Cerner Corp for a total of $28B 2020's second-largest software company dives into the healthcare sector Oracle Corporation (NYSE: ORCL), one of the U
General Motors Has Dipped 11% In The Last Week – Buying Opportunity?
GM'S annual gains have been slashed more than 10% in the last week The departure of Cruise CEO & Chevrolet production halt increased selling momentum Based on the long-term outlook, will the dip attract buyers
Does Blackberry Stock Hold Potential Ahead of Q322 Earnings?
Blackberry's business shift is stirring up the cybersecurity market, but that isn't it... Ahead of Q3 earnings, Blackberry stock is down 3% In what seems like an age ago now
Why You Should Buy Palantir As They Expand Into The Commercial Space
Investors have remained cautious regarding Palantir's Government contracts Partnership with Dewpoint Therapeutics furthers endeavor into commercial space Palantir's big-data framework has the potential to a
Here’s Why Spruce Biosciences (SPRB) Stock Price Pulled Back From Multi-Month Highs
Key points: Spruce Biosciences stock was trading 20% lower during premarket hours. It appears investors were taking profits on their positions. The company’s l
Here’s Why Can-Fite Biopharma (CANF) Stock Price Soared 67.7% Premarket. What’s Next?
Key points: Cen Fite Biopharma announced that one of the patients in its phase II clinical study had a full recovery from liver cancer. The patient had been treated for hepatocellular ca
Rolls Royce Falls 3% On Qatari Investment In Small Nuclear Business
Rolls Royce Holding PLC (LON: RR) has fallen 3% on news of the Qatari investment into the small nuclear r
Oriole Resources (ORR) Shares Edged Higher on Upbeat Bibemi Drill Results
Key points: Oriole Resources released positive phase 2 drilling results from its Bibemi project. The company has started the third drilling phase and expects to report Q1 2022.
Society Pass Jumps 48% On Addition To Russell 2000 Index – Possibly Too Much?
Society Pass Inc (NASDAQ: SOPA) has jumped 48% premarket. The rise is on news it is to be part of the Russell 2000 Index from market open today.